Hatchtech Drug Patent Portfolio

Hatchtech owns 1 orange book drug protected by 5 US patents Given below is the list of Hatchtech's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10292389 Pediculicidal composition 17 Dec, 2034
Active
US7812163 Methods and compositions for controlling ectoparasites 28 Oct, 2026
Active
US8212038 Methods and compositions for controlling ectoparasites 16 Jul, 2024 Expired
US9357783 Methods and compositions for controlling ectoparasites 16 Jul, 2024 Expired
US9839631 Methods and compositions for controlling ectoparasites 16 Jul, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Hatchtech.

Activity Date Patent Number
Patent litigations
Email Notification 03 May, 2024 US7812163
Change in Power of Attorney (May Include Associate POA) 03 May, 2024 US8212038
Email Notification 03 May, 2024 US9357783
Change in Power of Attorney (May Include Associate POA) 03 May, 2024 US7812163
Change in Power of Attorney (May Include Associate POA) 03 May, 2024 US9357783
Email Notification 03 May, 2024 US9839631
Change in Power of Attorney (May Include Associate POA) 03 May, 2024 US9839631
Email Notification 03 May, 2024 US8212038
Email Notification 18 Apr, 2024 US10292389
Change in Power of Attorney (May Include Associate POA) 18 Apr, 2024 US10292389
Change in Power of Attorney (May Include Associate POA) 02 Apr, 2024 US10292389
Email Notification 02 Apr, 2024 US10292389
Patent Term Extension Certificate 11 Mar, 2024 US7812163
Withdrawal of Application for PTE 07 Mar, 2024 US8212038
Payment of Maintenance Fee, 12th Yr, Small Entity 03 Jan, 2024 US8212038


Hatchtech's Family Patents

Hatchtech drugs have patent protection in a total of 16 countries. It's US patent count contributes only to 27.3% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Hatchtech Drug List

Given below is the complete list of Hatchtech's drugs and the patents protecting them.


1. Xeglyze

Xeglyze is protected by 5 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10292389 Pediculicidal composition 17 Dec, 2034
(10 years from now)
Active
US7812163 Methods and compositions for controlling ectoparasites 28 Oct, 2026
(2 years from now)
Active
US8212038 Methods and compositions for controlling ectoparasites 16 Jul, 2024
(2 months ago)
Expired
US9357783 Methods and compositions for controlling ectoparasites 16 Jul, 2024
(2 months ago)
Expired
US9839631 Methods and compositions for controlling ectoparasites 16 Jul, 2024
(2 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xeglyze's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List